RECRUITING

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Talk to us

Conditions

Peripheral Nerve StimulationChemotherapy-induced Peripheral Neuropathy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.

Official Title

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Quick Facts

Study Start:2024-02-22
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06162403

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants diagnosed with chronic (≥90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds or ionizing irradiation) of the lower extremity, seen at Pain Management Center at MD Anderson Cancer Center
  2. * Participants reports baseline pain ≥ 4 (0-10 scale, NRS)
  3. * Participants between ages 18-85 years old
  4. * Participants who have completed chemotherapy within the previous year at the time of enrollment
  1. * Participants with cognitive dysfunction
  2. * Participants with recent history (\<6 months) of drug or alcohol abuse
  3. * Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection
  4. * Participants with allergies to local anesthesia, steroids, or adhesives
  5. * Pregnant participants
  6. * Participants with conditions that conflict with the SPRINT PNS System Indications for Use, including Contraindications and Warnings.

Contacts and Locations

Study Contact

Saba Javed, MD
CONTACT
(713) 792-9530
sjaved@mdanderson.org

Principal Investigator

Saba Javed, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Saba Javed, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-22
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2024-02-22
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Peripheral Nerve Stimulation
  • Chemotherapy-induced Peripheral Neuropathy